A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD
Brooke L. Sevchik, S. Parker Singleton, Analiese Lahey, Pim Cuijpers, Mathias Harrer, Megan T. Jones, Sandeep M. Nayak, Eric C. Strain, Simon N. Vandekar, David B. Yaden, Robert H. Dworkin, J. Cobb Scott, Theodore D. Satterthwaite Neuropsychopharmacology
· Springer Nature
· 2026-10-11
· DOI: 10.1038/s41386-026-02575-z
Аннотация
Neuropsychopharmacology, Published online: 11 October 2026; doi:10.1038/s41386-026-02575-z A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD
Brooke L. Sevchik, S. Parker Singleton, Analiese Lahey, Pim Cuijpers, Mathias Harrer, Megan T. Jones et al. A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD. // Neuropsychopharmacology. – 2026. – DOI: 10.1038/s41386-026-02575-z. – URL: https://www.nature.com/articles/s41386-026-02575-z
Brooke L. Sevchik, S. Parker Singleton, Analiese Lahey, Pim Cuijpers, Mathias Harrer, Megan T. Jones, Sandeep M. Nayak, Eric C. Strain, Simon N. Vandekar, David B. Yaden, Robert H. Dworkin, J. Cobb Scott, & Theodore D. Satterthwaite (2026). A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD. Neuropsychopharmacology. https://doi.org/10.1038/s41386-026-02575-z
Brooke L. Sevchik, et al. “A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD.” Neuropsychopharmacology, 2026. doi:10.1038/s41386-026-02575-z.
@article{Sevchik2026,
title = {A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD},
author = {Sevchik, Brooke L. and Singleton, S. Parker and Lahey, Analiese and Cuijpers, Pim and Harrer, Mathias and Jones, Megan T. and Nayak, Sandeep M. and Strain, Eric C. and Vandekar, Simon N. and Yaden, David B. and Dworkin, Robert H. and Scott, J. Cobb and Satterthwaite, Theodore D.},
journal = {Neuropsychopharmacology},
year = {2026},
doi = {10.1038/s41386-026-02575-z},
url = {https://www.nature.com/articles/s41386-026-02575-z}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...